1) Hepatitis C
丙型肝炎
1.
Observation on Peg-IFN alpha-2β Combined with Capsule Ribavirin in Treatment Drug Addicts with Chronic Hepatitis C;
聚乙二醇干扰素α-2b联合利巴韦林治疗静脉药瘾者慢性丙型肝炎38例疗效观察
2.
Binhai Area Unpaid Blood Donors Prevalence of Hepatitis B and Hepatitis C Survey;
滨海地区无偿献血者乙型肝炎和丙型肝炎流行情况调查
3.
Identification and Clinical Significance of Liver Specific Autoantibodies in Patients With Hepatitis C;
丙型肝炎病毒感染患者血清肝特异性自身抗体的检测及临床研究
2) HCV
丙型肝炎
1.
Four years clinical analysis of 50 cases of hemophilia patients co-infected by AIDS/HCV treated with active antiretroviral therapy;
50例血友病合并艾滋病和丙型肝炎患者反转录病毒药物四年治疗的临床分析
2.
Cinical Significance of Detection of HCV Infection with FQ-PCR;
荧光定量聚合酶链反应检测丙型肝炎病毒的临床应用
3.
Epidemiological investigation of HCV infections in different populations in Qingyuan City;
清远市不同人群丙型肝炎感染的流行病学调查
3) hepatitis C virus
丙型肝炎
1.
Cloning and expression of non-structural protein 4B gene of hepatitis C virus in yeast;
丙型肝炎病毒非结构蛋白NS4B基因酵母表达载体的构建及表达
2.
[Methods]The hepatitis C virus were detected by ELISA.
[目的]探讨输血后丙型肝炎的临床特点。
3.
This program was that the promoter of the human 2′-5′-oligoadenylate synthetase gene which could be specific activated by hepatitis C virus core protein activated recombination caspase-3 in order to induce apoptosis of the HCV-infected hepatic cells.
丙型肝炎是常见的传染病,目前尚缺乏特异性的治疗方法,而特异性的基因治疗策略可能是一种理想的方案。
4) Chronic hepatitis C
丙型肝炎
1.
Usage of serum HLA-Ia expression levels for predicting the effect of interferon therapy in chronic hepatitis C patients;
HLA-Ia表达水平在预测干扰素治疗丙型肝炎疗效中的运用
2.
Clinical Studies on the Combination of PEG-IFN α-2a with RBV to Treat Chronic Hepatitis C;
聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型肝炎的临床研究
3.
Methods: 20 patients with chronic hepatitis C were treated with interferon-alpha and ribavirin for 24 weeks.
目的 :探讨细胞因子在慢性丙型肝炎发病机制中的作用。
5) C hepatitis
丙型肝炎
1.
Clinical function of conjoined testing for HCV-RNA and anti-HCV in final diagnosis of C hepatitis;
HCV-RNA和抗-HCV的联合检测在丙型肝炎确诊中的临床意义
6) Hepatitis C virus (HCV) / hepatitis C
丙型肝炎病毒/丙型肝炎
补充资料：丙型肝炎
丙型肝炎
丙型肝炎病毒主要通过丙型肝炎病人及丙型肝炎病毒携带者传播。发病前1～2个月，其血液即有传染性，亦可持续带毒1～2年以上。传播途径主要是血液及血制品传染。国内外输血后肝炎多由丙肝引起，母婴传播亦有可能。丙型肝炎病毒(HCV)感染后易导致慢性肝炎，其发生率较乙型肝炎更高，至少40%～50%患者转为慢性，最后发展为肝硬化和肝癌。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条